Join us this year for the 10th anniversary of the vervesymposium.com/ !!!
30 Nov - 2 Dec 2023
212
In this fascinating interview, Dr Gary Roubin discusses the origins of interventional cardiology and peripheral vascular interventions, including the influence of his mentor Andreas Gruentzig.
podcasts.google.com/feed/aHR…
230
On Thursday the VERVE Symposium will be hosting a special event to discuss the BEST-CLI Trial. It will be held at 7.30am at the ICC, immediately prior to the meeting opening
vervesymposium.com/
@anzsvs @BEST_CLI
VERVE Symposium retweeted
Dr. Andrew Holden & Prof. Ramon Varcoe (@RamonVarcoeMD) summarize our issue on SFA treatment that features global experts sharing the latest updates in above-the-knee interventions.
evtoday.com/articles/2022-se…
Check out the preliminary program for our 2022 VERVE Symposium and consider joining us in Sydney for the face-2-face meeting
vervesymposium.com/program/
VERVE Symposium retweeted
1/Today published in @JACCJournals is the 1st global consensus document on IVUS use for lower ext arterial & venous revasc. This document involved >40 international multidisciplinary experts in vascular disease & was led by a 12 person steering committee.
https://nitter.cf/t.co/Hzridqneb4
The VERVE Symposium is back in 2022 as a fully face-to-face conference once again!!!
Check out our preliminary at vervesymposium.com/program/ and mark your calenders for 1-3 December.
We can't wait to see you all again back in Sydney!
VERVE Symposium retweeted
...when embracing new technology, where the @VEITHsymposium came from and how it's evolved over the last 48yrs.
Fascinating insights into this eminent vascular leader.
@EVToday @VascularNews @hmpVDM @docmrjaff @roblookstein @VIVAPhysicians @VascularSVS @RKTvascular @VascularMD
VERVE Symposium retweeted
A new study shows an inverse relationship between
operator volume and perioperative S/D rates following CEA and CAS in ANZ. Is it time to consider minimum operator thresholds and networked referral pathways to improve patient outcomes? @anzsvs
journals.sagepub.com/eprint/…
VERVE Symposium retweeted
Dr. Ross Milner presenting at the 2019 @VERVEsymposium in Sydney, Australia on the topic of TEVAR. Welcome back to the chilly weather, Dr. Milner! #vervesymposium #tevar
VERVE Symposium retweeted
Jim Iliopoulos @VERVEsymposium on how special forces combat care truths are echoed in #vascularsurgery
Evolution in Special Forces Trauma Training & #Trauma Care/Surgery Since Afghanistan & Iraq
VERVE Symposium retweeted
open #vascularsurgery isn’t dead & #bypass is still a solid option for certain patients with critical limb ischemia! excellent talk @VERVEsymposium by @RKTvascular – at Sydney, New South Wales
VERVE Symposium retweeted
Excellent and thoughtful discussion of the role of surgical bypass in #CLTI by @RKTvascular @VERVEsymposium
VERVE Symposium retweeted
Replying to @VERVEsymposium
@VERVEsymposium today. Fabulous presentation by @JillSommerset on pedal artery acceleration time. Such an important adjunctive study for patients. Thanks for the work preparing the remote presentation. Lots of positive feedback. #vascularsonographers #vascularultrasound .
VERVE Symposium retweeted
@garyansel discussing the impending shortage of #vascular specialists in the US healthcare system @VERVEsymposium
VERVE Symposium retweeted
Brilliant presentation by @VascularMD on FEVAR/BEVAR for failed EVARs. @VERVEsymposium !
VERVE Symposium retweeted
Replying to @VERVEsymposium
@VERVEsymposium in full flow. Sven Braunlich from Leipzig updating on the Lutonix IDE Clinical Trial. @RamonVarcoeMD @DrShannonThomas
VERVE Symposium retweeted
Join us @VERVEsymposium for a presentation by Marianne Brodmann, MD on the above- and below-the-knee TOBA study results for the Tack Endovascular System®. #DissectionsMatter #PAD
Benefit/risk info: tinyurl.com/y2npbppm
Two days to go to the 2019 VERVE Symposium...Poised to be the best event we've ever run...Don't miss out...Register now!!! vervesymposium.com/
1
4


















